106 related articles for article (PubMed ID: 9473795)
1. Inhibition of experimental murine tumors by MT81, a new mycotoxin from Penicillium nigricans.
Gupta M; Majumdar UK; Ray MR; Mukhopadhayay DK
Neoplasma; 1997; 44(5):329-33. PubMed ID: 9473795
[TBL] [Abstract][Full Text] [Related]
2. Toxicological potential of mycotoxin MT81 and its benzoylated derivative on testicular spermatogenesis and steroidogenesis in mature male Wistar albino rats.
Choudhury SM; Gupta M; Majumder UK
Toxicol Mech Methods; 2011 Jun; 21(5):426-33. PubMed ID: 21417635
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic activities of MT81 and its structural analogue in Ehrlich ascites carcinoma-bearing Swiss Albino mice.
Choudhury SM; Gupta M; Majumder UK
Oxid Med Cell Longev; 2010; 3(1):61-70. PubMed ID: 20716929
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice [corrected].
Gupta M; Mazumder UK; Kumar RS; Kumar TS
Acta Pharmacol Sin; 2004 Aug; 25(8):1070-6. PubMed ID: 15301742
[TBL] [Abstract][Full Text] [Related]
5. Tumor inhibition and hematological improvements by dopamine analog 3,4-dihydroxybenzylamine in mice bearing transplantable carcinoma.
Lahiri T; Banerjee S; Dasgupta PS; Ray MR
Neoplasma; 1990; 37(4):387-93. PubMed ID: 2234200
[TBL] [Abstract][Full Text] [Related]
6. Effect of mycotoxins isolated from Penicillium nigricans on glucose-6-phosphate dehydrogenase.
Majumder UK; Gupta M; Mukhopadhyay DK
Indian J Exp Biol; 1997 Nov; 35(11):1233-6. PubMed ID: 9567755
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activities of mycotoxin MT81 and its structural derivatives.
Choudhury S; Rana MP; Chatterjee TK; Mazumder UK; Gupta M
Indian J Exp Biol; 1992 Feb; 30(2):140-1. PubMed ID: 1521863
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
9. Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine.
Lakshmi C; Deb C; Ray C; Ray MR
Neoplasma; 2005; 52(1):68-73. PubMed ID: 15739030
[TBL] [Abstract][Full Text] [Related]
10. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
11. Some enzymes and substrates of Embden-Meyerhof pathway of different tissues and related hormones of mycotoxin, MT81, treated mice.
Gupta M; Dey SN; Dolui AK; Mukherjee S; Basu SK; Batabyal SK
Indian J Exp Biol; 1988 Apr; 26(4):315-22. PubMed ID: 3169853
[No Abstract] [Full Text] [Related]
12. Growth retardation and prevention of Ehrlich solid tumor by Clostridium perfringens type A spores and culture supernatant.
Lapointe JR; Portelance V
Cancer Res; 1978 Aug; 38(8):2295-300. PubMed ID: 208766
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor activity of thevetoside alone and in combination with chlormethine in vivo].
Zhang XW; Huang ZQ; Li CC
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):285-8. PubMed ID: 7976390
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
Ghosh S; Maity P
Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
[TBL] [Abstract][Full Text] [Related]
16. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate.
Chakraborty P; Sk UH; Bhattacharya S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):971-80. PubMed ID: 19221751
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of methanolic extract of Cassia fistula L. seed against Ehrlich ascites carcinoma.
Gupta M; Mazumder UK; Rath N; Mukhopadhyay DK
J Ethnopharmacol; 2000 Sep; 72(1-2):151-6. PubMed ID: 10967466
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
